Liver involvement in cystic fibrosis. A report of 9 cases.

Prevalence of liver disease in cystic fibrosis. Arch Dis Child (1991) 1.61

Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Child (1994) 0.92

Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch Dis Child (1996) 0.90

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 4.39

Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67

A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med (1999) 2.86

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51

Osmosensing and osmoregulatory compatible solute accumulation by bacteria. Comp Biochem Physiol A Mol Integr Physiol (2001) 2.36

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann Oncol (2008) 2.28

Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med (1994) 2.26

Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21

Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development (2000) 2.18

Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance. Thromb Haemost (2001) 2.16

Identification and mapping of human cDNAs homologous to Drosophila mutant genes through EST database searching. Nat Genet (1996) 2.13

Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet (1963) 2.12

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients. Ann Oncol (2007) 2.11

Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09

Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand (1978) 1.98

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet (1985) 1.88

Plasma protein S deficiency in familial thrombotic disease. Blood (1984) 1.82

Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab (2000) 1.78

Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP) Thromb Haemost (1999) 1.69

Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism (1982) 1.65

Binding of disease-associated prion protein to plasminogen. Nature (2000) 1.64

The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr (1995) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Screening of JAK2 V617F mutation in multiple myeloma. Leukemia (2006) 1.59

The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol (2012) 1.57

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients. Br J Cancer (2008) 1.55

Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol (1993) 1.55

Salivary cortisol levels throughout childhood and adolescence: relation with age, pubertal stage, and weight. Pediatr Res (1995) 1.54

The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications. Am J Hum Genet (1996) 1.53

Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor. J Thromb Haemost (2009) 1.52

Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol (2000) 1.51

Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol (1995) 1.49

Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46

Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. J Pediatr (2003) 1.44

Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol (Oxf) (1998) 1.43

Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits. Shock (1998) 1.43

dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin Exp Rheumatol (1997) 1.43

Tracheal-innominate artery fistula caused by the endotracheal tube tip: case report and investigation of a fatal complication of prolonged intubation. Respir Care (2001) 1.42

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. J Antibiot (Tokyo) (1981) 1.42

Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet (1996) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Patient compliance with homeopathic therapy. Homeopathy (2006) 1.41

[Effect of air pollutant burden on healthy children and children with lung diseases in southern Ticino]. Schweiz Med Wochenschr (1989) 1.41

The rise and fall of i-STAT point-of-care blood gas testing in an acute care hospital. Am J Clin Pathol (2000) 1.40

CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol (1995) 1.40

Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. Am J Hematol (1996) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Growth hormone deficiency in children with chromosomal abnormalities. Arch Dis Child (1990) 1.39

CYP21 mutations in simple virilizing congenital adrenal hyperplasia. J Mol Med (Berl) (2001) 1.39

Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. Eur J Pediatr (1988) 1.39

[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39

FORTRAN interface for code interoperability in quantum chemistry: the Q5Cost library. J Chem Inf Model (2007) 1.39

Auditory hallucinations suppressed by etizolam in a patient with schizophrenia. Can J Psychiatry (1993) 1.38

Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod (2000) 1.38

Terrestrial gamma-ray flashes as powerful particle accelerators. Phys Rev Lett (2011) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33

Studies with ubiquinone-depleted submitochondrial particles. Effects of extraction and reincorporation of ubiquinone on the kinetics of succinate dehydrogenase. Eur J Biochem (1970) 1.33

Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32

Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes (2001) 1.32

Effect of whole-body x-ray irradiation on phospholipids of rat liver particulate fractions. Arch Biochem Biophys (1965) 1.31

Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost (2007) 1.28

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood (2001) 1.28

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

DiGeorge anomaly associated with 10p deletion. Am J Med Genet (1991) 1.25

Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion (2001) 1.24

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer. Br J Cancer (2012) 1.24

Intensive utilisation of a dialysis unit. Proc Eur Dial Transplant Assoc (1973) 1.23

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost (2005) 1.22

Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab (2003) 1.22

Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.22

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Intestinal side-effects of docetaxel/vinorelbine combination. Lancet (2000) 1.19

Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol (1992) 1.19

Airway obstructions associated with congenital heart disease in infancy. J Thorac Cardiovasc Surg (1990) 1.18

Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.17

Intracellular levels of the LIS1 protein correlate with clinical and neuroradiological findings in patients with classical lissencephaly. Ann Neurol (1999) 1.16

Interaction between rifampicin and trimethoprim in vitro and in experimental infections. J Antimicrob Chemother (1977) 1.16

Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood (2000) 1.16

Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res (1983) 1.16

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion (1998) 1.15

The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory. Nutr Metab Cardiovasc Dis (2010) 1.15

Replicon clusters may form structurally stable complexes of chromatin and chromosomes. J Cell Sci (1994) 1.13

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Long-term cimetidine in children with cystic fibrosis: a randomized double-blind study. Pediatr Res (1984) 1.11

Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc (1987) 1.11

p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol (2000) 1.10

Endorectal ultrasound: instrumentation and clinical aspects. Int J Colorectal Dis (1986) 1.10

Primary cerebral lymphoma: the "ghost tumor". Case report. J Neurosurg (1984) 1.08

Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Mol Cell Biol (1994) 1.08

Rapid procedure for fecal porphyrin assay. Clin Chem (1985) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Inter- and intrachromosomal rearrangements are both involved in the origin of 15q11-q13 deletions in Prader-Willi syndrome. Am J Hum Genet (1997) 1.07

Dialysis schedule and peripheral neuropathy. Proc Eur Dial Transplant Assoc (1973) 1.07

Customizing CellSearch platform. Cytometry A (2013) 1.07